1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 22
2.2 Major Growth Drivers 24
2.3 Market Restraints and Challenges 29
2.4 Emerging Opportunities and Market Trends 32
2.5 Porters Fiver Forces Analysis 36
3 Segmentation of North America Market by Source 40
3.1 Market Overview by Source 40
3.2 Human 42
3.3 Humanized 43
3.4 Chimeric 44
3.5 Murine 45
4 Segmentation of North America Market by Category 46
4.1 Market Overview by Category 46
4.2 Branded mAbs 48
4.3 Biosimilar mAbs 49
5 Segmentation of North America Market by Production Type 50
5.1 Market Overview by Production Type 50
5.2 In Vitro Production 52
5.3 In Vivo Production 53
6 Segmentation of North America Market by Application 54
6.1 Market Overview by Application 54
6.2 Cancer 56
6.2.1 Breast Cancer 58
6.2.2 Colorectal Cancer 59
6.2.3 Lung Cancer 60
6.2.4 Ovarian Cancer 61
6.2.5 Other Cancer Types 62
6.3 Autoimmune Diseases 63
6.4 Inflammatory Diseases 64
6.5 Infectious Diseases 65
6.6 Other Applications 66
7 Segmentation of North America Market by End User 67
7.1 Market Overview by End User 67
7.2 Hospitals 69
7.3 Research Institutes 70
7.4 Other End Users 71
8 North America Market 2019-2030 by Country 72
8.1 Overview of North America Market 72
8.2 U.S. 75
8.3 Canada 78
8.4 Mexico 80
9 Competitive Landscape 82
9.1 Overview of Key Vendors 82
9.2 New Product Launch, Partnership, Investment, and M&A 85
9.3 Company Profiles 86
Abbott Laboratories 86
AbbVie, Inc. 88
Amgen Inc. 89
AstraZeneca plc 90
Bayer AG 91
Bristol-Myers Squibb Company 92
Eli Lilly 93
F. Hoffmann-La Roche Ltd. 94
GlaxoSmithKline Plc 95
Johnson & Johnson 96
Merck & Co., Inc. 97
Mylan N.V 98
Norvatis AG 99
Pfizer 100
Sanofi S.A. 101
RELATED REPORTS 102